Lv4
426 积分 2023-09-01 加入
An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development
13天前
已完结
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective
13天前
已完结
Application of Pharmacometrics in Advancing the Clinical Research of Antibody-Drug Conjugates: Principles and Modeling Strategies
17天前
已完结
Establishing in vitro–in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approach
19天前
已完结
Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads
1个月前
已完结
The Correlation Between Pharmacodynamics and Pharmacokinetics: Basics of Pharmacokinetics‐Pharmacodynamics Modeling
1个月前
已完结
A Phase I Dose‐Finding Design Incorporating Intra‐Patient Dose Escalation
1个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
1个月前
已完结
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group
3个月前
已完结
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
3个月前
已完结
皖公网安备34019202002308
